CEO & MD, James McBrayer talks lung disease screening

Cyclopharm Limited (ASX:CYC) CEO & Managing Director, James McBrayer provides an update on the company’s Technegas lung imaging technology, sales and US regulatory timeframe.

Privacy Preference Center


We use cookies to better understand your use of this website.

Google Analytics, IRM Investor Centre

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?